RELAY THERAPEUTICS
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.
RELAY THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.relaytx.com
Total Employee:
101+
Status:
Active
Contact:
(617)370-8837
Email Addresses:
[email protected]
Total Funding:
870 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-16 | ZebiAI | ZebiAI acquired by Relay Therapeutics | 85 M USD |
Investors List
Foresite Capital
Foresite Capital investment in Series C - Relay Therapeutics
Tavistock Group
Tavistock Group investment in Series C - Relay Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Relay Therapeutics
Alexandria Venture
Alexandria Venture investment in Series C - Relay Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Relay Therapeutics
Casdin Capital
Casdin Capital investment in Series C - Relay Therapeutics
D. E. Shaw Research
D. E. Shaw Research investment in Series C - Relay Therapeutics
GV
GV investment in Series C - Relay Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series C - Relay Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series C - Relay Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-05-14 | Relay Therapeutics adds artificial intelligence exec |
Official Site Inspections
http://www.relaytx.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.23 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Relay Therapeutics"
Relay Therapeutics
Our world-class team is highly integrated, collaborative and entrepreneurial. Find a career at Relay Therapeutics that’s right for you. Relay Therapeutics® puts protein motion at the heart of drug …See details»
Careers - Relay Therapeutics
Relay invites extraordinarily creative, talented and passionate individuals to join us as we strive to make a difference in patients' lives.See details»
Who We Are - Relay Therapeutics
Relay Therapeutics® is a clinical-stage precision medicine company that sits at the intersection of computational and experimental technologies. We are focused on making small molecule medicines against precision medicine targets with …See details»
Relay Therapeutics - Crunchbase Company Profile
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion. Relay Therapeutics received a positive outlook and a reiterated buy rating from analysts. The …See details»
Relay Therapeutics - LinkedIn
Integrating leading-edge computational and experimental science to transform human health. Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery...See details»
Investors & Media - Relay Therapeutics
CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Relay Therapeutics, a biotech company dedicated to developing breakthrough medicines by focusing on insights in protein motion, today …See details»
Relay Therapeutics - Craft
Relay Therapeutics has 5 employees at their 1 location, $520 m in total funding, and $25.55 m in annual revenue in FY 2023. See insights on Relay Therapeutics including office locations, …See details»
Relay Therapeutics Announces Positive Interim Data for RLY-2608 ...
CAMBRIDGE, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process …See details»
Our Team - Relay Therapeutics
We’re always on the lookout for people who take what they do seriously, without taking themselves too seriously. What are you waiting for? Come join us! Our world-class team is equal parts bright and bold, with a shared passion for …See details»
Relay Therapeutics Discloses Three New Programs at New …
Jun 6, 2024 · 3 new programs include 2 genetic disease programs – vascular malformations & Fabry disease – & 1 precision oncology program – NRAS-specific inhibitor. Cash guidance …See details»
Relay Therapeutics Announces Clinical Trial Collaboration with …
Jun 5, 2024 · RLY-2608 is the lead program in Relay Therapeutics’ efforts to discover and develop mutant selective inhibitors of PI3Kα, the most frequently mutated kinase in all …See details»
Relay Therapeutics - Overview, News & Similar companies
Mar 27, 2024 · Relay Therapeutics contact info: Phone number: (617) 370-8837 Website: www.relaytx.com What does Relay Therapeutics do? Relay Therapeutics is a biotechnology …See details»
Alexis Borisy – Relay Therapeutics
Alexis is currently founder and executive chairman of EQRx, a new pharma company committed to making innovative medicines at dramatically lower prices for the benefit of people and society.See details»
Relay Therapeutics to Host New Program and Platform Event on …
May 13, 2024 · Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental …See details»
Pat Walters, Ph.D. - Relay Therapeutics
As Chief Data Officer, Pat Walters oversees the development and application of the computational components of Relay Therapeutics’ Dynamo ® platform. Prior to joining Relay Therapeutics, …See details»
Relay Therapeutics to Announce Third Quarter 2024 Financial …
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental …See details»
Our Science - Relay Therapeutics
Relay Therapeutics® is advancing a pipeline of promising therapeutic candidates designed to solve problems that were previously intractable or inadequately addressed with traditional drug …See details»
Relay Therapeutics Announces Positive Interim Data for RLY-2608 ...
Sep 9, 2024 · 9.2-month median PFS in heavily pre-treated patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer at RP2D. 33% ORR across all patients & 53% ORR in …See details»
Press Releases - Relay Therapeutics
The Investor Relations website contains information about Relay Therapeutics's business for stockholders, potential investors, and financial analysts.See details»
Relay Therapeutics Reports Second Quarter 2024 Financial Results …
Aug 6, 2024 · Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and …See details»